Navigation Links
Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50%
Date:2/26/2008

BEVERLY HILLS, Calif., Feb. 26 /PRNewswire/ -- At Beverly Hills Liposculpture, Dr. Alan Bittner (http://www.dralanbittner.com) offers women a minimally invasive and safe breast reduction surgery that can reduce breasts by up to 50% without scaring or associated risks. The procedure, called liposculpture breast reduction, takes approximately 90 minutes and can remove up to 1 liter of fat (more than 3 coke cans!) from each breast while the patient is awake. Female breast reduction by liposculpture reduces the size and weight of the breasts, can correct for asymmetry present in natural breasts, and provides a mild to moderate degree of breast lift.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/bhliposculpture/31945/

According to Dr. Alan Bittner, Medical Director of Beverly Hills Liposculpture (http://www.bhliposculpture.com), the busiest liposculpture center in the world, "Breast liposculpture is done in our office in Beverly Hills with local numbing; no general anesthesia or IV sedation is used. Our patients remain awake and alert during the procedure." Most patients report that the procedure is comfortable or is virtually pain free. As a micro-liposculpture specialist, Dr. Bittner uses a gentle technique with instruments that are smaller than an angel hair pasta noodle to remove between 40 to 70% of the fat in the breasts. These smaller instruments lead to more precise results and faster recovery.

"There are many advantages of female breast reduction by liposculpture over traditional breast reduction surgery: No general anesthesia or IV is needed; there are no stitches or unattractive scars, there is very little pain and most patients return to work the following day," says Dr. Alan Bittner. (

SOURCE Beverly Hills Liposculture
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer
2. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
3. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
4. Video and Photo: U.S. Department of Health & Human Services and Ad Council Join NFL to Combat Childhood Obesity
5. Photo: Introducing a New Line of Baby and Toddler Shirts that Can Help Protect Innocent Babies During Flu Season
6. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
7. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
8. Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders
9. Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
10. Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles
11. Photo: KFC Colonel Original and Look-a-Like Share Eye Treatment Success Story

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...PRNewswire/ -- Menopause - it,s an unavoidable par...f uncomfortable symptoms that negatively impact qu...s, weight gain , night sweats and lethargy are ju... and perimenopause. What,s worse, menopause signs... actual menopause occurs (perimenopause), and can ...
(Date:11/30/2009)...Uses Tent To Simulate High Altitude, Low O2 Condit...wire/ -- Distance runners who live at high altitud...ir performance during races in areas that are at s... from fatigue, improve their exercise performance ...? ,, That is the question being studied among 1...
(Date:11/30/2009)...PRNewswire/ -- The launch of Invivo Corporation,s ...rst FDA-cleared, fully-automated morphological sys...t of suspicious breast lesions. The ONCAD system w...iety of North America 2009 Annual Meeting in Chica...perts in breast MRI, ONCAD for DynaCAD uses a pate...
(Date:11/30/2009)...results in animals , , MONDAY, Nov. 30...ggest that stem cells from transplanted human-deri...g and heart disorders. , Scientists already kn...ong list of different kinds of cells in the labora...ter in Seoul, Korea, co-author of one of the studi...
(Date:11/30/2009)...ire/ --- Salon Leau announced today they are hosti... raise funds and create positive impact in the fig...ds from each haircut and or color will be donated ...alon Leau has been serving the posh Washington DC ...widely recognized for her innovation in color, cut...
Breaking Medicine News(10 mins):Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2
... Insurance Coverage Exclusions for,Pre-existing Co..., WASHINGTON, Oct. 26 The National Patient,Advoc...ganization dedicated,to the mission of creating av...(D-WV) for acting to protect Americans at,risk of ...
...iental,Bioengineering, Inc. (NYSE: AOB ), a leadi...rmaceutical and nutraceutical products in China, t...l investor conferences in,November. The Company w...nagement is currently scheduled to present at,1:55...
...d Companies Control Health Care Costs, DALLAS, Oc...cs" Kenneth H. Cooper, M.D., M.P.H., Cooper Aerobi...r acquisition in the company,s 37-year,history. Co...Benefits merges traditional employee benefits cons...
...n Jack Group, Inc.,(MattsonJack) announces the rel... Database(TM) is designed to help clients make str...g of the importance of mutually,exclusive and over...nd Comorbidity Database(TM) -- Med 2.0, which feat...
...Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the...nced that data from a 12-month study of DAYTRANATM...on Deficit Hyperactivity Disorder (ADHD) patch, de...esented today at a major scientific and educationa...
...ty is a societal problem that needs to be solved. ...patitis or NASH, is just one of the many complicat...or NASH are limited, and therefore there is an unm...ing hand to potentially aid in abolishing the occu...
Other Medicine News:Health News:National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage 2Health News:American Oriental Bioengineering Announces Participation in November Healthcare Conferences 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 3Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 4Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Long-term 12-month safety data on ADHD patch DAYTRANA 2Health News:Attenuation of NASH by stimulation of free fatty acid metabolism 2
(Date:11/30/2009)...PRNewswire-FirstCall/ -- NightHawk Radiology Servi...o radiology groups and hospitals throughout the Un...Assurance (QA) program to foster better communicat... and to deliver superior patient care. ,, Nig... program in several presentations at RSNA 2009. Ni...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Surgical Incision Closures - Global Trends ...al-Incision-Closures---Global-Trends.html ,, S...gnificance, due to the millions of surgical proced...es such as cardiology, obstetrics/gynecology, orth...
(Date:11/30/2009)...RNewswire/ -- Cytokine PharmaSciences, Inc. today ...I-2364, its orally active, small-molecule inhibito...lammatory cytokines. Results of the safety and to...eers confirm the safety of this compound in initia...ts completed the study, including those receiving ...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Young leukemia and lymphoma patients live longer today than in years past 55090 1Young leukemia and lymphoma patients live longer today than in years past 55090 2The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 1The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 2U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 1U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 2
...l 2 Novo Nordisk today announced that the Endocri...the United States Food and Drug Administration (FD...ted to liraglutide, a once-daily human GLP-1 analo...ns related to the risk profile of liraglutide. , ...bers supported that appropriate evidence of cardio...
...2 Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Co...e discovery and development of novel antibiotics f...s, today announced that its lead compound, delaflo...tors for the 8th annual report on "100 Great Inves...ue. , , R&D Directions is a leading pharmaceu...
Other Medicine Technology:Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 2Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 4
34670x Bagolini's Striated Lenses Pair
BD Visitec IOL Manipulator (Fenzl)
BD Visitec IOL Manipulator (Lester)
Maltzman-Fenzl Lens Manipulator
Medicine Products: